Table 1 |
|||
|
Clinical data of five patients with rheumatoid arthritis at the time of joint surgery a |
|||
|
Patient |
Disease durationb, months |
Site of surgery |
Medication |
|
|
|||
|
1 |
74 |
Knee |
MTX 15 mg/wk, SSZ 1 g/d, Pd 5 mg/d |
|
2 |
60 |
Knee |
NSAIDs |
|
3 |
97.5 |
Knee |
Pd 10 mg/d |
|
4 |
121 |
Knee |
Pd 10 mg/d |
|
5 |
180 |
Hip |
HCQ 200 mg/d |
|
|
|||
|
aAge of the patients was 57.0 ± 15.6 years (age range 35 to 73 years), and they were all female. bDisease duration is the time interval between symptom onset of rheumatoid arthritis and joint replacement surgery. HCQ, hydroxychlorquine; MTX, methotrexate; NSAID, nonsteroidal anti-inflammatory drug; Pd, prednisolone; SSZ, sulfasalazine. |
|||
|
Kang et al. Arthritis Research & Therapy 2009 11:R130 doi:10.1186/ar2797 |
|||